Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Two high-profile biotech CEOs assess impact of reform bill
Two high-profile biotech CEOs assess impact of reform bill
Two high-profile biotech CEOs assess impact of reform bill
Submitted by
admin
on April 2, 2010 - 10:01am
Source:
Fierce Biotech
News Tags:
healthcare reform
Biogen Idec
Jim Mullen
Genzyme
Henri Termeer
Headline:
Two high-profile biotech CEOs assess impact of reform bill
Do Not Allow Advertisers to Use My Personal information
